← Back to all trials
Not Yet Recruiting
NCT05701540
A Study to Evaluate the Efficacy and Safety of Tegoprazan in GERD Patients With Nighttime Heartburn
Conditions: Gastroesophageal Reflux Disease
Sex: All
Ages: 19 Years – 75 Years
Phase: PHASE4
Enrollment: 338
Sponsor: HK inno.N Corporation
Location: Korea, Republic of
Summary
This study aims to compare the nighttime heartburn improvement effect of Tegoprazan 50mg and Esomeprazole 40mg(or 20mg) in patients with GERD.
Eligibility Criteria
Inclusion Criteria:Subjects aged between 19 and 75 yearsSubjects who have erosive reflux disease or non-erosive reflux diseaseExclusion Criteria:Unable to undergo upper GI endoscopySymptoms of primary or secondary esophageal movement disordersSubjects who have undergone or are scheduled to undergo surgery that can affect gastric acid secretion(e.g.
upper gastrectomy, vagotomy, etc)
Source: ClinicalTrials.gov (NCT05701540). StuddyBuddy aggregates publicly available trial information.
